Structural equation modeling of immunotoxicity associated with exposure to perfluorinated alkylates Children's Environmental Health

Environmental Health: A Global Access Science Source

Volumn 14, Issue 1, 2015, Pages

  Mogensen, Ulla B ^a   Grandjean, Philippe ^b,c   Heilmann, Carsten ^d   Nielsen, Flemming ^c   Weihe, Pál ^e   Budtz Jorgensen, Esben ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d University of Copenhagen   (Denmark)

^e FAROESE HOSPITAL SYSTEM   (Faroe Islands)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUORO COMPOUND; PERFLUOROHEXANESULFONIC ACID; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; UNCLASSIFIED DRUG; ALKANESULFONIC ACID; ANTIBODY; FLUOROCARBON; IMMUNOLOGIC FACTOR; IMMUNOTOXIN; OCTANOIC ACID DERIVATIVE; POLLUTANT;

ANIMAL COMMUNITY; ANTIBODY; BACTERIAL DISEASE; CHILD HEALTH; COHORT ANALYSIS; CONCENTRATION (COMPOSITION); IMMUNOASSAY; ORGANOFLUORINE; POLLUTION EXPOSURE; SERUM; TOXICITY;

AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; COHORT ANALYSIS; CONCENTRATION RESPONSE; DIPHTHERIA; EXPOSURE; FAROESE; FEMALE; HUMAN; IMMUNOTOXICITY; MALE; PRIORITY JOURNAL; STRUCTURAL EQUATION MODELING; TETANUS; TOXICITY TESTING; ADVERSE EFFECTS; BLOOD; COMPARATIVE STUDY; DENMARK; ENVIRONMENTAL EXPOSURE; IMMUNOLOGY; POLLUTANT; PRESCHOOL CHILD; TIME FACTOR;

FAROE ISLANDS;

ANIMALIA;

ALKANESULFONIC ACIDS; ANTIBODIES; CAPRYLATES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; DIPHTHERIA; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOTOXINS; MALE; TETANUS; TIME FACTORS;

EID: 84933512586     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/s12940-015-0032-9     Document Type: Article

References (29)

1. Lindstrom AB, Strynar MJ, Libelo EL. Polyfluorinated compounds: past, present, and future. Environ Sci Technol. 2011;45(19):7954-61.
2. Weihe P, Kato K, Calafat AM, Nielsen F, Wanigatunga AA, Needham LL, et al. Serum concentrations of polyfluoroalkyl compounds in Faroese whale meat consumers. Environ Sci Technol. 2008;42(16):6291-5.
3. DeWitt JC, Peden-Adams MM, Keller JM, Germolec DR. Immunotoxicity of perfluorinated compounds: recent developments. Toxicol Pathol. 2012;40(2):300-11.
4. Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS, Keil DE. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci. 2008;104(1):144-54.
5. Fair PA, Driscoll E, Mollenhauer MA, Bradshaw SG, Yun SH, Kannan K, et al. Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice. J Immunotoxicol. 2011;8(1):17-29.
6. Dietert RR. Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment. J Immunotoxicol. 2008;5(4):401-12.
7. Grandjean P, Andersen EW, Budtz-Jorgensen E, Nielsen F, Molbak K, Weihe P, et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA. 2012;307(4):391-397.
8. Olsen GW, Burris JM, Ehresman DJ, Froehlich JW, Seacat AM, Butenhoff JL, et al. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environ Health Perspect. 2007;115(9):1298-305.
9. Bartell SM, Calafat AM, Lyu C, Kato K, Ryan PB, Steenland K. Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect. 2010;118(2):222-8.
10. Kato K, Calafat AM, Wong LY, Wanigatunga AA, Caudill SP, Needham LL. Polyfluoroalkyl compounds in pooled sera from children participating in the National Health and Nutrition Examination Survey 2001-2002. Environ Sci Technol. 2009;43(7):2641-7.
11. Luo Z, Shi X, Hu Q, Zhao B, Huang M. Structural evidence of perfluorooctane sulfonate transport by human serum albumin. Chem Res Toxicol. 2012;25(5):990-2.
12. Kim DH, Lee MY, Oh JE. Perfluorinated compounds in serum and urine samples from children aged 5-13 years in South Korea. Environ Pollut. 2014;192:171-8.
13. Budtz-Jorgensen E, Keiding N, Grandjean P, Weihe P. Estimation of health effects of prenatal methylmercury exposure using structural equation models. Environ Health. 2002;1(1):2.
14. Sanchez BN, Budtz-Jorgensen E, Ryan L, Hu H. Structural equation models: a review with applications to environmental epidemiology. J Am Stat Assoc. 2005;100(472):1443-55.
15. Hastie TJ, Tibshirani RJ. Generalized additive models. In monographs on statistics and applied probability 43. Boca Raton, FL: Chapman and Hall/CRC Press; 1990.
16. Kline RB. Principles and practice of structural equation modeling. 3rd ed. New York: Guilford Press; 2011.
17. Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. Hoboken: Wiley; 2002.
18. Core Team R. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2012.
19. Holst KK, Budtz-Jorgensen E. Linear latent variable models: the lava-package. Comput Stat. 2013;28:1385-452.
20. Corsini E, Sangiovanni E, Avogadro A, Galbiati V, Viviani B, Marinovich M, et al. In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). Toxicol Appl Pharmacol. 2012;258(2):248-55.
21. Eliakim A, Schwindt C, Zaldivar F, Casali P, Cooper DM. Reduced tetanus antibody titers in overweight children. Autoimmunity. 2006;39(2):137-41.
22. Carroll R, Ruppert D, Stefanski LA, Crainiceanu CM. Measurement error in nonlinear models: a modern perspective. 2nd ed. Boca Raton, FL: Chapman and Hall/CRC Press; 2006.
23. VanderWeele TJ. Invited commentary: structural equation models and epidemiologic analysis. Am J Epidemiol. 2012;176(7):608-12.
24. Granum B, Haug LS, Namork E, Stolevik SB, Thomsen C, Aaberge IS, et al. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol. 2013;10(4):373-9.
25. Fei C, McLaughlin JK, Lipworth L, Olsen J. Prenatal exposure to PFOA and PFOS and risk of hospitalization for infectious diseases in early childhood. Environ Res. 2010;110(8):773-7.
26. C8 Science Panel. Status Report: PFOA and immune biomarkers in adults exposed to PFOA in drinking water in the mid Ohio valley. March 16. C8 Science Panel (Tony Fletcher, Kyle Steenland, David Savitz). http://www.c8sciencepanel.org/study-results.html. Accessed 13 Jun 2013.
27. Looker C, Luster MI, Calafat AM, Johnson VJ, Burleson GR, Burleson FG, et al. Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate. Toxicol Sci. 2014;138(1):76-88.
28. Heilmann C, Budtz-Jorgensen E, Nielsen F, Heinzow B, Weihe P, Grandjean P. Serum concentrations of antibodies against vaccine toxoids in children exposed perinatally to immunotoxicants. Environ Health Perspect. 2010;118(10):1434-8.
29. Grandjean P, Budtz-Jorgensen E. Immunotoxicity of perfluorinated alkylates: calculation of benchmark doses based on serum concentrations in children. Environ Health. 2013;12:35.